Squarepoint’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
Other funds holding EVGN
AIM
SCM
SM
EVC
Squarepoint's EVGN Position: Q4 2021 in Review
Squarepoint sold out of Evogene (EVGN) in Q4 2021, closing a stake of 4,530 shares — an estimated $120K sold.
Squarepoint first reported a position in EVGN in Q3 2020 and held it in 5 quarters. The position peaked at $576K in Q1 2021. 42 funds tracked by Wall St. Rank hold EVGN as of Q4 2021.
- Squarepoint reported no remaining Evogene position as of Q4 2021 after selling out during the quarter.
- Squarepoint sold 4,530 Evogene shares in Q4 2021, an estimated $120K.
- Squarepoint first reported a position in Evogene in Q3 2020 and held it in 5 quarters.
- Squarepoint's Evogene position peaked at $576K in Q1 2021.
- 42 funds tracked by Wall St. Rank held Evogene as of Q4 2021.
Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.